If Llanberis upgraded their facility to be flexible with changes. What’s keeping them from transferring Immulite manufacturing from the US manufacturing sites to there and still build the reagents . Seems like a logical thing to do would be to build everything in the same building . … Or is that to come?
3 replies (most recent on top)
This is definitely happening. Not sure if that wasn't public knowledge previously.
They already do the reagent manufacturing and just upgraded their building. We are talking about the Immulite instruments. US production on XPI and Versacell is way down. They could easily transfer it like they did Atellica products.
That's cute that you think that site would get reagent manufacturing over Walpole, when Walpole has an entire building of lab space just waiting to be turned on.